← Eichor
Study identifier: NCT07319442 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

CEDUR - German IBD Registry

Condition: Ulcerative Colitis (UC) · Indeterminate Colitis · Crohn Disease (CD)  ·  Sponsor: ImmunoRegister gUG

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.

This description comes directly from the study's public registry record.

Talk to the study team

Stefanie Howaldt, MD  ·  +4940423265150  ·  Howaldt@immunoregister.de

Always discuss trial participation with your own doctor first.

Locations (1)

ImmunoRegister gUGHamburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07319442